SCHEMBL21600859

SCHEMBL21600859

C=CC(=O)Nc1cc(N2CCN(C)CC2)ccc1Nc1ncc(C#N)c(-c2cn(C)c3ccccc23)n1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 1/20 0.62
▸ CCNB1 P14635 1/20 0.62
▸ CCNE1 P24864 1/20 0.62
▸ CDK2 P24941 1/20 0.62
▸ FLT3 P36888 1/20 0.62
▸ CDK7 P50613 1/20 0.62
▸ CCNH P51946 1/20 0.62
▸ MNAT1 P51948 1/20 0.62
▸ EGFR P00533 17/20 0.60
▸ IGF1R P08069 1/20 0.60
▸ KCNH2 Q12809 1/20 0.60
▸ JAK3 P52333 1/20 0.52
▸ MAP3K7 O43318 1/20 0.49
▸ FGFR1 P11362 1/20 0.49
▸ SRC P12931 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ MAP2K1 Q02750 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21600860 0.92 EGFR (0.53) CDK1CCNB1CCNE1CDK2FLT3
SCHEMBL14663910 0.86 EGFR (0.73) EGFRIGF1RKCNH2
SCHEMBL21600798 0.85 EGFR (0.51) CDK1CCNB1CCNE1CDK2FLT3
SCHEMBL30379569 0.85 EGFR (0.51) CDK1CCNB1CCNE1CDK2FLT3
SCHEMBL28537203 0.84 EGFR (0.49) CDK1CCNB1CCNE1CDK2FLT3
SCHEMBL21596377 0.84 EGFR (0.49) CDK1CCNB1CCNE1CDK2FLT3
SCHEMBL30379774 0.84 EGFR (0.49) CDK1CCNB1CCNE1CDK2FLT3
SCHEMBL21601035 0.81 EGFR (0.49) CDK1CCNB1CCNE1CDK2FLT3
SCHEMBL21601029 0.80 EGFR (0.51) CDK1CCNB1CCNE1CDK2FLT3
SCHEMBL21601002 0.80 EGFR (0.48) CDK1CCNB1CCNE1CDK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019242689-A1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2019-12-26 — — WO disclosed
Send feedback